Literature DB >> 17371437

Loss of maspin expression contributes to a more invasive potential in malignant melanoma.

Alexandra E Denk1, Marcus Bettstetter, Peter J Wild, Keith Hoek, Frauke Bataille, Wolfgang Dietmaier, Anja K Bosserhoff.   

Abstract

Deregulation of protease expression and activity is known to play an important role in tumour progression of malignant melanoma. The serpin maspin, a tumour suppressor in breast and prostate cancer was described as an inhibitor of cell migration and inducer of cell adhesion between the basement membrane and extracellular matrix resulting in inhibition of tumour metastasis. In contrast, overexpression of maspin is correlated with poor prognosis in other cancers. However, little is known about expression, regulation and function of maspin in malignant melanoma. In this study, we found loss of maspin expression in malignant melanoma cells compared with normal human epidermal melanocytes, which was analysed by quantitative real-time PCR, Western blot analysis, immunohistochemistry and microarray. For functional studies, melanoma cell clones stably transfected with a maspin expression vector were tested for changes in proliferation, migration and invasion. Although we could not see differences in proliferation and migration, we detected strongly reduced invasive capacity in the melanoma cell clones in which maspin is re-expressed compared with control. Reduced invasive potential was also detected in three different melanoma cell lines transiently transfected with a maspin expression vector. Furthermore, exogenously added maspin alone was sufficient to reduce invasion in MelIm significantly, indicating that maspin directly inhibits invasion on the cell surface. In summary, we believe that maspin is a tumour suppressor in malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371437     DOI: 10.1111/j.1600-0749.2007.00363.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  17 in total

1.  Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.

Authors:  Gabriel J Villares; Maya Zigler; Andrey S Dobroff; Hua Wang; Renduo Song; Vladislava O Melnikova; Li Huang; Russell R Braeuer; Menashe Bar-Eli
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Internalization by multiple endocytic pathways and lysosomal processing impact maspin-based therapeutics.

Authors:  Thomas M Bodenstine; Richard E B Seftor; Elisabeth A Seftor; Zhila Khalkhali-Ellis; Nicole A Samii; J Cesar Monarrez; Grace S Chandler; Philip A Pemberton; Mary J C Hendrix
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

Review 3.  Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target.

Authors:  Eleonore Fröhlich
Journal:  Cell Mol Life Sci       Date:  2010-08-05       Impact factor: 9.261

Review 4.  Aberrant DNA methylation in malignant melanoma.

Authors:  Carolina Schinke; Yongkai Mo; Yiting Yu; Kathy Amiri; Jeff Sosman; John Greally; Amit Verma
Journal:  Melanoma Res       Date:  2010-08       Impact factor: 3.599

5.  Slit3 inhibits Robo3-induced invasion of synovial fibroblasts in rheumatoid arthritis.

Authors:  Alexandra E Denk; Simone Kaufmann; Klaus Stark; Jörg Schedel; Torsten Lowin; Thomas Schubert; Anja K Bosserhoff
Journal:  Arthritis Res Ther       Date:  2010-03-18       Impact factor: 5.156

6.  Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.

Authors:  Luca Sigalotti; Alessia Covre; Elisabetta Fratta; Giulia Parisi; Francesca Colizzi; Aurora Rizzo; Riccardo Danielli; Hugues J M Nicolay; Sandra Coral; Michele Maio
Journal:  J Transl Med       Date:  2010-06-11       Impact factor: 5.531

7.  Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT.

Authors:  S McKenzie; S Sakamoto; N Kyprianou
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

8.  Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer.

Authors:  Eswar Shankar; Mitali Pandey; Shiv Verma; Ata Abbas; Mario Candamo; Rajnee Kanwal; Sanjeev Shukla; Gregory T MacLennan; Sanjay Gupta
Journal:  Mol Carcinog       Date:  2020-05-11       Impact factor: 4.784

9.  Highly expressed histone deacetylase 5 promotes the growth of hepatocellular carcinoma cells by inhibiting the TAp63-maspin pathway.

Authors:  Hongqian Gu; Zejun Fang; Xiang Cai; Rui Song; Min Lin; Jiangwei Ye; Xiaokun Ding; Qinjian Ke; Haihong Chen; Chaoju Gong; Ming Ye
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

10.  Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells.

Authors:  Frédéric R Santer; Kamilla Malinowska; Zoran Culig; Ilaria T Cavarretta
Journal:  Endocr Relat Cancer       Date:  2010-02-18       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.